BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9633012)

  • 1. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence.
    Beck-Speier I; Dayal N; Maier KL
    J Biolumin Chemilumin; 1998; 13(2):91-9. PubMed ID: 9633012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988.
    Bates EJ; Harvey DP; Ferrante A
    Int Arch Allergy Immunol; 1992; 97(1):50-6. PubMed ID: 1582698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfite induces release of lipid mediators by alveolar macrophages.
    Beck-Speier I; Dayal N; Denzlinger C; Haberl C; Maier KL
    Z Naturforsch C J Biosci; 1998; 53(3-4):264-72. PubMed ID: 9618940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
    Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
    Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs.
    Kato M; Tokuyama K; Morikawa A; Kuroume T; Barnes PJ
    Eur J Pharmacol; 1993 Feb; 232(1):7-12. PubMed ID: 8384564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
    Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 11. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.
    Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G
    Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
    Warren JS; Barton PA; Mandel DM; Matrosic K
    Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
    Chen J; Ziboh V; Giri SN
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat.
    Del Sorbo L; DeMartino A; Biancone L; Bussolati B; Conaldi PG; Toniolo A; Camussi G
    Eur J Immunol; 1999 May; 29(5):1513-21. PubMed ID: 10359105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulphite on the oxidative metabolism of human neutrophils: studies with lucigenin- and luminol-dependent chemiluminescence.
    Mishra A; Dayal N; Beck-Speier I
    J Biolumin Chemilumin; 1995; 10(1):9-19. PubMed ID: 7762419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles.
    Tool AT; Koenderman L; Kok PT; Blom M; Roos D; Verhoeven AJ
    Blood; 1992 May; 79(10):2729-32. PubMed ID: 1586719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.